Tumor necrosis factor (TNF) is widely recognized as a pivotal player in both systemic and local inflammatory processes. Due to the critical role this molecule has in driving both chronic and acute inflammation, it was among the earliest therapeutic targets utilized for pa-tients with autoimmune (AI) diseases. While inflamma-tion in the prostate is commonly observed, the organ has not previously been considered a target of systemic inflammation associated with some AI diseases. In pa-tients with benign prostatic hyperplasia (BPH), chronic inflammation is common, and immune cells represent a significant proportion of cells in the organ. Accumulation of inflammatory cells may be a response to an initial in-sult and/or a factor in driving BPH pathogenesis. Cer-tainly, inflammation can limit the efficacy of existing medical therapies in these patients. We previously showed that a pattern of gene expression in BPH tissues from patients who had progressed to indication-specific surgery was consistent with the changes seen in AI dis-eases. Recently, we demonstrated that patients with AI disease have an approximately 50% increase in (…)
Cell Stress (CES) emerges as a peer-reviewed publishing platform for high-impact research. CES publishes articles of extraordinary novelty and significance, including research papers and reviews that cover heterogenous topics in the field of cellular pathophysiology. CES is an open access online journal that thus allows its readership and general public around the world to read, download, store, distribute or print any article free of charge. Long-term archiving and accessibility of all published articles is secured through partnership with different repositories, including PubMed Central. At the same time, our open access policy ensures fast publication as well as high visibility and broad divulgence of the author’s published research. The financing of this policy is sustained by charging a publication fee/article processing charges (APCs). By pursuing an open access approach and the universal accessibility to scientific knowledge, we support the return to one of the essential values of science: the free exchange of ideas.
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.